Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -208,518 | -128,225 | -51,694 | -152,148 | -108,723 |
| Depreciation Amortization | -4,319 | -3,840 | -2,225 | -8,057 | -6,263 |
| Accounts payable and accrued liabilities | 10,285 | 5,492 | 1,597 | -3,453 | -6,516 |
| Other Working Capital | 12,630 | 3,944 | -9,438 | 2,660 | 3,388 |
| Other Operating Activity | 18,812 | 13,425 | 7,354 | 26,319 | 22,617 |
| Operating Cash Flow | $-171,110 | $-109,204 | $-54,406 | $-134,679 | $-95,497 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -528 | -395 | -187 | -972 | -327 |
| Purchase Of Investment | -285,947 | -187,251 | -89,992 | -703,015 | -409,000 |
| Sale Of Investment | 400,897 | 232,307 | 106,246 | 278,958 | 205,681 |
| Other Investing Activity | -800 | -800 | -750 | 0 | 0 |
| Investing Cash Flow | $113,622 | $43,861 | $15,317 | $-425,029 | $-203,646 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,794 | 1,997 | 1,533 | 645,913 | 298,602 |
| Common Stock Repurchased | N/A | N/A | N/A | -13 | -13 |
| Other Financing Activity | 19,821 | 19,821 | 0 | -39,227 | -17,871 |
| Financing Cash Flow | $22,615 | $21,818 | $1,533 | $606,673 | $280,718 |
| Beginning Cash Position | 92,646 | 92,646 | 92,646 | 45,681 | 45,681 |
| End Cash Position | 57,773 | 49,121 | 55,090 | 92,646 | 27,256 |
| Net Cash Flow | $-34,873 | $-43,525 | $-37,556 | $46,965 | $-18,425 |
| Free Cash Flow | |||||
| Operating Cash Flow | -171,110 | -109,204 | -54,406 | -134,679 | -95,497 |
| Capital Expenditure | -528 | -395 | -187 | -972 | -327 |
| Free Cash Flow | -171,638 | -109,599 | -54,593 | -135,651 | -95,824 |